Tele: 561.316.3330
Breaking Medical Device News

Tuesday, October 19, 2021

HomeMedHubMedHub's AI-powered Solutions Are Disrupting Cardiology

MedHub’s AI-powered Solutions Are Disrupting Cardiology

The software company is commencing its pivotal multi-center clinical trial, aimed at demonstrating the efficacy of their ground-breaking product, AutocathFFR

The company MedHub develops decision-support systems for cardiologists that leverage Artificial Intelligence (AI) to guide cardiologists during the diagnostic cardiac angiography process.

The fully automated system, named AutocathFFR, detects stenoses (narrowing) in the coronary arteries surrounding the heart, while providing cardiologists with relevant physiological parameters that aid them in assessing the severity of their patients’ condition. In doing so, the system helps these physicians devise the optimal treatment strategy.

Following a successful feasibility study, done in close collaboration with the Rambam Healthcare Campus, a leading facility in the field of interventional cardiology, MedHub is now in the initial stages of a pivotal multi-center clinical trial to demonstrate the efficacy of AutocathFFR. The results of the feasibility study will be published at the upcoming, highly prestigious, ICI conference.

Statistics show that with current standard diagnostic methods, occurrence of re-stenosis stands at 15%. Moreover, clinically unnecessary interventions, including stent placement procedures, have reached 30%, costing the American healthcare system roughly $4 billion each year. These troubling incidents are a result of inaccurate diagnoses and are therefore preventable.

MedHub considers its first product, AutocathFFR, part of the current movement towards automizing medical practices. With the advent of AI, the road to full Robotic Process Automation (RPA) in cardiac diagnostics is getting shorter.

MedHub has goaled itself with optimizing diagnoses, thus lowering costs, improving the long-term effects of treatment and achieving better overall outcomes in terms of quality of life. “As interventional cardiologists performing catheterizations on a daily basis, we face significant challenges in accurate diagnosis of cardiac disease that stem from difficulty in precisely assessing the severity of a patient’s condition and in making the appropriate connections between a patient’s complaints and the subsequent diagnosis. This makes tailoring an optimal and personalized course of treatment difficult, at best” says Dr. Edward Koifman, a senior

cardiologist at Soroka Medical Center, and CMO of MedHub. “AI is revolutionizing medicine. We are already seeing its impact on diagnosis and treatment precision in a variety of medical fields. I believe that this kind of technology will assist cardiologists in the decision-making process when determining the best course of action.” Dr. Koifman is only one of several key people in the cardiology space who are part of the MedHub team.

“Nowadays, we fly in automated airplanes and rely on smart navigation systems in our private cars to make better decisions than we do. I don’t see why we shouldn’t make use of similar capabilities when it comes to our health and well-being” says Or Bruch-El, the CEO of MedHub. He continues, “healthcare systems everywhere, are burning-out and collapsing under immense loads, making quality of treatment directly dependent on patient access to private capital. AI has the potential to change that. Our reality calls for it.” About MedHub, he adds “I believe there is tremendous clinical and economic potential for all stakeholders, including clinicians, patients and payors.”

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced...

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

By using this website you agree to accept Medical Device News Magazine Privacy Policy